Search results

Insights into the crystallisation process of twin crystals important for drug production.

Collaboration across the Tasman has enabled Australian and New Zealand researchers and scientists to shed light on a protein involved in diseases such as Parkinson’s disease, gastric cancer and melanoma.

ITRAX has now analysed more than a kilometre of cores since it became operational in 2012.

ANSTO sets out the following terms and conditions relating to users who access our facilities for the purpose of research.

Recently, a small delegation, including Yandruwandha Yawarrawarrka representatives from the remote outback settlement of Innamincka SA, travelled to ANSTO to deliver rare wooden Aboriginal archaeological artefacts for measurements to determine their age and origin.

ANSTO undertakes a rigorous environmental monitoring program and shares expertise nationally and internationally.

Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape

The National Deuteration Facility offers access to deuterated molecules prepared by both in vivo biodeuteration and chemical deuteration techniques.

The Australian Nuclear Science and Technology Organisation (ANSTO) has joined a team, lead by the US Department of Energy’s Pacific Northwest National Laboratory (PNNL), to install a high resolution monitoring system at ANSTO’s medical isotope production facility in Lucas Heights, Australia.

ANSTO has provided supporting experimental evidence of a highly unusual quantum state, a quantum spin liquid (QSL), in a two-dimensional material.